Does finding a rare mutation accomplish anything?

Apr 10, 2024 | Episode 81 | 5 mins

Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.

Download or subscribe to our recurring podcasts.

Apple Podcasts Google Podcasts Spotify RSS

Illumina financial solutions

NextSeq 1000 and NextSeq 2000 Reagents

Sequencing Platform Comparison Tool

Rethink what’s possible with DRAGEN analysis

Illumina Proactive Instrument Performance Service

Do more, faster than ever

Learning about our own genomes through primates

Learning about our own genomes through primates

Learning about our own genomes through primates

Learning about our own genomes through primates

Learning about our own genomes through primates

Learning about our own genomes through primates

Learning about our own genomes through primates

This is the Genome Era

This is the Genome Era

This is the Genome Era

This is the Genome Era

This is the Genome Era

This is the Genome Era

This is the Genome Era

Illumina DRAGEN Secondary Analysis v4.2

Illumina DRAGEN Secondary Analysis v4.2

Illumina DRAGEN Secondary Analysis v4.2

Illumina DRAGEN Secondary Analysis v4.2

Illumina DRAGEN Secondary Analysis v4.2

Illumina DRAGEN Secondary Analysis v4.2

TruSight Oncology 500 ctDNA v2 is now available

TruSight Oncology 500 ctDNA v2 is now available

TruSight Oncology 500 ctDNA v2 is now available

TruSight Oncology 500 ctDNA v2 is now available

TruSight Oncology 500 ctDNA v2 is now available

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

The race results are in—with marine genomic data

The race results are in—with marine genomic data

The race results are in—with marine genomic data

The race results are in—with marine genomic data

The race results are in—with marine genomic data

Shriners Children’s and specialized pediatric care

Shriners Children’s and specialized pediatric care

Shriners Children’s and specialized pediatric care

Shriners Children’s and specialized pediatric care

Shriners Children’s and specialized pediatric care

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

“Tripledemic” pathogen surveillance is critical

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

A new era for clinical labs

Announcing Illumina Complete Long Reads

Announcing Illumina Complete Long Reads

Announcing Illumina Complete Long Reads

Announcing Illumina Complete Long Reads

Does finding a rare mutation accomplish anything?

The Illumina Genomics Podcast

Does finding a rare mutation accomplish anything?

Download or subscribe to our recurring podcasts.